EUVIMEDEUVIMED entdecken
Open Access

TTK is a potential regulator of tumor progression correlated with dedifferentiation and immune cell infiltration in papillary thyroid cancer

Jun-Jie Ma, Cheng Xiang, Jian-Wei Wang

Aging · 15.10.2023 · 15 (19) · 10607-10626

DOI: 10.18632/aging.205100 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging, online erschienen am 06.10.2023. Verfasst von Jun-Jie Ma und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thyroid Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, Zhejiang, China. Hauptthemen laut MEDLINE: MicroRNAs, Thyroid Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To investigate the role and clinical significance of threonine tyrosine kinase (TTK) in papillary thyroid cancer (PTC). METHODS: TTK expression in PTC and normal groups were compared using TCGA data and in vitro experiments. The prognostic value of TTK and its possible role in PTC dedifferentiation was evaluated. Next, TTK involvement in PTC occurrence and progression was analyzed via in vitro experiments. Subsequently, analyses of enrichment and immune cell infiltration were conducted to reveal the possible mechanism. Finally, we predicted the target miRNAs followed by performing a luciferase reporter experiment. RESULTS: TTK upregulation was observed in PTC, and its elevated level was significantly related to an unfavorable prognosis (P < 0.05). Interestingly, TTK negatively correlated with thyroid differentiation score (TDS), and patients with higher TDS showed longer survival (all P < 0.05). PTC cell growth, migration, and invasion were inhibited upon TTK knockdown. Besides, TTK was involved in metabolic processes and regulated cell adhesion molecules pathway. Its overexpression was positively associated with immune cell infiltrates (P < 0.05). Moreover, miR-582-5p was an upstream target of TTK. CONCLUSION: TTK serves as a potential biomarker for tumorigenesis and prognosis in PTC, especially for those that may differentiate into more aggressive thyroid cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsThyroid NeoplasmsHumansThyroid Cancer, PapillaryProtein Serine-Threonine KinasesProtein-Tyrosine KinasesCell Line, TumorCell MovementCell ProliferationGene Expression Regulation, NeoplasticCell Cycle Proteins

Stichwörter der Autor:innen

TTKbiomarkerpapillary thyroid cancerprognosistumorigenesis

Substanzen

Protein Serine-Threonine KinasesProtein-Tyrosine KinasesMicroRNAsTTK protein, humanCell Cycle ProteinsMIRN582 microRNA, human

Autor:innen und Institutionen

  • Department of Thyroid Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, Zhejiang, China.
  • The Colorectal Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, Zhejiang, China.

Zitieren

APA

Ma, J. J., Xiang, C., & Wang, J. W. (2023). TTK is a potential regulator of tumor progression correlated with dedifferentiation and immune cell infiltration in papillary thyroid cancer. Aging, 15(19), 10607-10626. https://doi.org/10.18632/aging.205100

Vancouver

Ma JJ, Xiang C, Wang JW. TTK is a potential regulator of tumor progression correlated with dedifferentiation and immune cell infiltration in papillary thyroid cancer. Aging. 2023;15(19):10607-10626. doi:10.18632/aging.205100

BibTeX
@article{Ma2023,
  author = {Ma, Jun-Jie and Xiang, Cheng and Wang, Jian-Wei},
  title = {TTK is a potential regulator of tumor progression correlated with dedifferentiation and immune cell infiltration in papillary thyroid cancer},
  journal = {Aging},
  year = {2023},
  volume = {15},
  number = {19},
  pages = {10607--10626},
  doi = {10.18632/aging.205100}
}
Kostenlos starten →